CVS Health (CVS) named Ed DeVaney president of the company’s CVS Caremark pharmacy benefit management business. He was named interim president in December 2024. DeVaney will report to Prem Shah, group president, CVS Health.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- Third Point buys Capital One, cuts Microsoft in Q4
- CVS Health price target raised to $74 from $58 at RBC Capital
- CVS Health price target raised to $70 from $66 at Deutsche Bank
- CVS Health Corp’s Mixed Earnings Call Highlights Growth and Challenges
- CVS Health price target raised to $76 from $60 at Truist